In a research report issued Friday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), and reduced …
Brean Capital analyst Ananda Baruah weighed in with a few insights on Stratasys, Ltd. (NASDAQ:SSYS), after the 3D printer maker reported its second-quarter results, posting …
Brean Capital analyst Mike Burton weighs in on shares of semiconductor company Qorvo Inc (NASDAQ:QRVO) following the company’s first quarter results for the fiscal year of …
Shares of Integrated Device Technology Inc (NASDAQ:IDTI) are down 10% to $19.97, after the analog chip maker reported disappointing revenue and EPS guidance, as …
Keryx Biopharmaceuticals (NASDAQ:KERX) shares are tumbling nearly 12% in early trading, following an impending supply interruption for key pipeline drug, Auryxia, a drug created …
Shares of Baidu Inc (ADR) (NASDAQ:BIDU) are falling nearly 5% to $157.76 in early trading Friday, after the Chinese Internet search provider posted mixed second-quarter results, with earnings per …
Brean Capital analyst Ananda Baruah weighs in on Apple Inc. (NASDAQ:AAPL) following its third quarter results.
Analyst Difei Yang of Brean Capital feels reassured about the Relypsa Inc’s (NASDAQ:RLYP) ascending success, calling attention to its up-and-coming potassium-binding Valtassa, a beta …
In a research report published Friday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), with …
Analyst Alan Gould of Brean Capital highlighted three issues that could affect Walt Disney Co’s (NYSE:DIS) stock in the short term. Firstly, he has doubts that ESPN …
